Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $135.87 --0%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Interest expense: -242M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $0.99, $0.04 better than the analyst estimate of $0.95. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.29 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
